DW4421

DRUG4 trials

Sponsors

Daewon Pharmaceutical Co., Ltd.

Conditions

GERD (Gastroesophageal Reflux Disease)Healthy AdultHealthy Adult VolunteerHealthy Adult Volunteers

Phase 1

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

RecruitingNCT07343245

Daewon Pharmaceutical Co., Ltd.Healthy Adult

Start: 2025-12-01End: 2026-06-17Target: 150Updated: 2026-01-15

Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

CompletedNCT07364838

Daewon Pharmaceutical Co., Ltd.GERD (Gastroesophageal Reflux Disease)

Start: 2024-11-21End: 2025-04-08Updated: 2026-01-23

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Enrolling by invitationNCT07364877

Daewon Pharmaceutical Co., Ltd.Healthy Adult Volunteer

Start: 2025-12-28End: 2026-05-18Target: 38Updated: 2026-01-23

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Not yet recruitingNCT07382661

Daewon Pharmaceutical Co., Ltd.Healthy Adult Volunteers

Start: 2026-02-01End: 2026-10-01Target: 36Updated: 2026-02-04